F5, Inc. (NASDAQ:FFIV – Get Free Report) insider John Maddison sold 204 shares of the stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $406.24, for a total transaction of $82,872.96. Following the completion of the sale, the insider directly owned 1,149 shares of the company’s stock, valued at $466,769.76. This trade represents a 15.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
John Anthony Maddison also recently made the following trade(s):
- On Monday, August 3rd, John Maddison sold 1,000 shares of F5 stock. The shares were sold at an average price of $405.85, for a total transaction of $405,850.00.
F5 Stock Up 4.7%
Shares of NASDAQ FFIV traded up $19.39 during trading on Tuesday, reaching $430.88. 638,391 shares of the stock were exchanged, compared to its average volume of 732,461. The company has a market capitalization of $24.40 billion, a price-to-earnings ratio of 34.31, a price-to-earnings-growth ratio of 4.02 and a beta of 1.03. The business’s 50-day moving average price is $403.34 and its 200 day moving average price is $362.06. F5, Inc. has a twelve month low of $223.76 and a twelve month high of $435.00.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on FFIV shares. Evercore upgraded F5 from an “in-line” rating to an “outperform” rating and set a $475.00 target price for the company in a research note on Monday, May 18th. Royal Bank Of Canada reiterated an “outperform” rating on shares of F5 in a research note on Thursday, July 16th. Wall Street Zen raised F5 from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. JPMorgan Chase & Co. raised their price objective on F5 from $500.00 to $515.00 and gave the company an “overweight” rating in a research note on Tuesday, July 28th. Finally, Morgan Stanley lifted their price objective on F5 from $380.00 to $415.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 28th. Five investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $416.62.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in FFIV. BlackRock Inc. bought a new stake in shares of F5 in the 2nd quarter worth about $2,611,637,000. Jericho Capital Asset Management L.P. bought a new position in shares of F5 during the fourth quarter worth about $579,699,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in F5 by 24.8% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 726,844 shares of the network technology company’s stock valued at $302,338,000 after buying an additional 144,534 shares in the last quarter. William Blair Investment Management LLC bought a new position in F5 during the 2nd quarter worth approximately $243,865,000. Finally, Amundi lifted its holdings in F5 by 96.0% during the 2nd quarter. Amundi now owns 555,809 shares of the network technology company’s stock worth $231,194,000 after buying an additional 272,273 shares during the last quarter. 90.66% of the stock is currently owned by institutional investors.
F5 Company Profile
F5, Inc is a technology company that provides application delivery, security and traffic-management solutions for enterprises, service providers and government organizations. Its offerings are designed to help customers ensure the availability, performance and security of applications across on-premises data centers, public clouds and edge environments.
The company’s portfolio includes BIG-IP software and appliances, NGINX application delivery and web server technologies, and F5 Distributed Cloud Services.
Recommended Stories
- Five stocks we like better than F5
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for F5 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for F5 and related companies with MarketBeat.com's FREE daily email newsletter.
